Soldiers deployed to tropical and sunny climates are coming home with increased risk factors for a threat far from the battlefield: skin cancer.

The factor ATF4 has a role in the toughness of bone and its resistance to fracture, suggesting new therapeutic targets.

A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication.

Having a “leaky” gut may protect against colitis, a paradoxical finding that alters understanding of the role of cell permeability in intestinal homeostasis and immune regulation.

Patients who suffer a longer duration of delirium in the intensive care unit are more likely to experience long-term disability after discharge.

A new mouse model reveals gene clusters important in a treatment-resistant form of leukemia.

Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer.